Getty Images Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Getty Images Holdings, Inc. (GETY) on March 17, 2026. The filing addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the Company's compliance with continued listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the Company's stock price performance relative to listing requirements.
Material Changes and Listing Status
- Notice of Non-Compliance: On March 17, 2026, the Company received written notice from the NYSE that it failed to meet the minimum bid price requirement under Section 802.01C of the NYSE Listed Company Manual.
- Trigger Event: The average closing price of the Company's Class A common stock was less than $1.00 over a consecutive 30 trading-day period.
- Immediate Impact: The notice does not result in immediate delisting. The stock will continue to be listed and traded on the NYSE during the cure period.
Guidance, Outlook, and Risks
- Cure Period: The Company has a six-month period from the date of the notice to regain compliance with the minimum share price requirement.
- Compliance Path: To regain compliance, the Company must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the preceding 30 trading-day period on the last trading day of any calendar month within the cure period.
- Management Intent: The Company intends to notify the NYSE within ten business days of its intent to cure the deficiency.
- Risks: The filing highlights the risk that the Company may fail to regain compliance within the six-month window, which could lead to delisting. Forward-looking statements regarding the cure are subject to uncertainties and actual results may differ materially.
Investor Verification Checklist
- Verify the current trading price and 30-day average of GETY Class A common stock to assess proximity to the $1.00 threshold.
- Review the Company's most recent Form 10-K (filed for the year ended December 31, 2025) for detailed risk factors and financial health.
- Monitor for the Company's formal notification to the NYSE regarding its intent to cure the deficiency within the next ten business days.
- Check for any subsequent press releases or filings detailing specific corporate actions (e.g., reverse stock splits) intended to address the share price deficiency.